We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Product Safety Report for Fair & White So White skin lightening cream presenting a serious chemical risk due to the presence of hydroquinone.
Product recall for Vernacare wetwipes and personal cleansing products, including bedbaths, shampoo caps, wash mitts, cleansing wipes and barrier cloths, presenting a risk of microbiological contamination due to the detection of Pseudomonas Aeruginosa.
Preliminary outbreak assessment for lumpy skin disease in Libya and East Asia.
Periodically perform skin examinations in patients on bendamustine-containing regimens and consider PML in the differential diagnosis for patients on bendamustine with new or worsening neurological, cognitive, or behavioural signs or symptoms.
A new campaign to raise awareness of the fire risk and the precautions that need to be taken by users of skin creams has been launched today
Rarely, severe adverse effects can occur on stopping treatment with topical corticosteroids, often after long-term continuous or inappropriate use of moderate to high potency products. To reduce the risks of these events, prescribe the topical corticosteroid of lowest potency needed...
The Medicines and Healthcare products Regulatory Agency has today issued a recall asking patients to return affected products.
Cases of severe cutaneous adverse reactions, including Stevens-Johnsons syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in patients treated with immune-stimulatory anti-cancer drugs, including atezolizumab. Advise patients to be vigilant for the signs of severe skin reactions and...
Advise patients treated with ingenol mebutate gel to be vigilant for new skin lesions and to seek medical advice immediately should any occur. Use with caution in patients with a history of skin cancer.
Systemic cardiovascular effects including bradycardia, hypotension, and dizziness have been reported after application. It is important to avoid application to irritated or damaged skin, including after laser therapy.
Product defect recall alert for: Otodex Skin Cream (Vm 13240/4000) by Petlife International Ltd
A new synthetic ‘skin’ has been developed that could be used to test new decontamination procedures
Monitor patients closely for skin cancers. Advise patients to seek urgent attention if they develop signs or symptoms of serious infections.
MSD successfully put their advanced new melanoma treatment through MHRA's early access to medicine scheme (EAMS).
World’s first clinical field trials of the BCG vaccine and DIVA skin test launched on a cattle farm in Hertfordshire.
Advise patients taking hydrochlorothiazide-containing products of the cumulative, dose-dependent risk of non-melanoma skin cancer, particularly in long-term use, and the need to regularly check for (and report) any suspicious skin lesions or moles. Counsel patients to limit exposure to sunlight...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.